You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VEGF inhibitor

Showing 1 - 25 of 8,775
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Chapel Hill (Survey Questionnaire)

Recruiting
  • Renal Cell Carcinoma
  • Survey Questionnaire
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 19, 2022

Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

Not yet recruiting
  • Lung Adenocarcinoma
  • +3 more
  • Serplulimab and Bevacizumab injection
  • (no location specified)
Dec 21, 2022

Colorectal Cancer, Microsatellite Instability High Trial in Guangzhou (PD-1 inhibitor plus VEGF inhibitors)

Recruiting
  • Colorectal Cancer
  • Microsatellite Instability High
  • PD-1 inhibitor plus VEGF inhibitors
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
May 27, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Ovarian Tumors, Recurrent Ovarian Carcinoma, Relapsed Ovarian Cancer Trial in Beijing (AK112 low dose, AK112 medium dose, AK112

Terminated
  • Ovarian Neoplasms
  • +3 more
  • AK112 low dose
  • +2 more
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
Oct 8, 2022

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)

Withdrawn
  • Stage II Renal Cell Cancer
  • Stage III Renal Cell Cancer
  • (no location specified)
Aug 11, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Colorectal Cancer Trial in London (Axitinib, Placebo)

Completed
  • Colorectal Cancer
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Apr 17, 2020

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

Lung Cancer, Nonsmall Cell, Renal Cell Carcinoma, Melanoma Trial in Sydney (Blood screening, Tissue screening)

Recruiting
  • Lung Cancer, Nonsmall Cell
  • +6 more
  • Blood screening
  • Tissue screening
  • Sydney, New South Wales, Australia
  • +1 more
Jan 19, 2022

Carcinoma, Renal Cell Trial in India, Russian Federation, Ukraine (Tivozanib (AV-951), Placebo comparator)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Tivozanib (AV-951)
  • Placebo comparator
  • Vellore, Tamil Nadu, India
  • +25 more
Aug 17, 2020

Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

Completed
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
  • +10 more
Dec 1, 2022

Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

Recruiting
  • Neuroendocrine Tumor
  • +4 more
  • Cabozantinib 40 mg
  • Badalona, Barcelona, Spain
  • +14 more
Feb 15, 2022

Serial PET MPI in Patients Undergoing Cancer Treatment

Enrolling by invitation
  • Cancer
  • +3 more
    • Los Angeles, California
      West Los Angeles VA Medical Center
    Jun 12, 2023

    Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

    Active, not recruiting
    Has Results
    • Endometrial Adenocarcinoma
    • +9 more
    • Bevacizumab
    • +5 more
    • Phoenix, Arizona
    • +232 more
    Jan 12, 2023

    Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

    Not yet recruiting
    • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
    • (no location specified)
    Jul 10, 2023

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    Ocular and Neurodevelopmental Function for Retinopathy of

    Recruiting
    • Retinopathy of Prematurity
    • Neurodevelopmental Abnormality
    • Severe ROP
    • Linkou, Taoyuan, Taiwan
      Department of Ophthalmology, Chang Gung Memorial Hospital.
    Jan 15, 2022

    Eales' Disease Trial in Portland (Ranibizumab)

    Completed
    Has Results
    • Eales' Disease
    • Portland, Oregon
      Casey Eye Institute
    Jun 9, 2019